Objective The goal of this study was to investigate transesophageal echocardiographic (TEE) findings after the termination of atrial fibrillation to clarify the direct evidence for occurrence of acute cardiogenic brain embolism (CBE) in patients with paroxysmal atrial fibrillation (PAF).
Introduction
According to the report from the National Institute of Neurological Disorders and Strokes, cardiogenic brain embolism (CBE) is classified as one of the important clinical categories, that is the most commoncause of death in the total mortality in patients with acute ischemic stroke (1-4). Furthermore, it is well known that patients with chronic nonvalvular atrial fibrillation have a more than 5-fold incidence of CBEcompared with the normal population (5). Experimental research suggests that atrial fibrillation leads to tachycardia-induced atrial mechanical remodeling and stunning that has been demonstrated to link this phenomenon to the formation of thrombus (6, 7). However, it remains uncertain howmuch the LAAdysfunction contributes to the occurrence of CBE in paroxysmal atrial fibrillation (PAF). It also remains unknown why some patients develop CBEand others do not during PAF. The goal of this study was to investigate TEEfindings after the termination of atrial fibrillation to clarify the direct evidence for occurrence of acute CBEin patients with PAF.
For editorial comment, see p 1059. 17 patients had chronic atrial fibrillation and 16 had PAF (Group CBE, male 10, female 6, 72±10 years, mean±SD). Fifteen age-and sex-matched PAF patients without CBE were used as control (Group N, male 10, female 5, 72±10 years). None of the patients had organic heart diseases or were treated with antiarrhythmic drugs before admission. Patients in both groups showed atrial fibrillation at admission and recovered to normal sinus rhythm within 2 days after the admission.
The duration from reversal to normal sinus rhythm to TEE examinations was 6±1 days in both groups. The termination of atrial fibrillation by antiarrhythmic drugs was successful in 4 cases in each group, and direct current cardioversion was performed in 3 cases in group CBE and 4 in group N. Other patients recovered to normal sinus rhythm spontaneously. In the study protocol, we examined echocardiographic parameters and hemostatic markers in group CBE within 7 days of the onset and 2 weeks after the first study, and compared to group N. The local ethics committee approved the protocol, and informed consent was obtained from all subjects. After the cardiac examination, the transducer was rotated posteriorly to obtain aortic images (29). The depth was set at 5 cm, and by using the transverse plane, the transducer was slowly withdrawn from the distal thoracic aorta to the aortic arch. Maximumintima-media thickness of the far wall of the aortic arch (aortic IMT) without protruding atheromatous plaques was measured at end-diastole if the intima-medial l ayer was continuously visible for five cardiac cycles (30 jug/ml, respectively (34-37). Continuous variables were expressed as mean±standard deviation or median. A Student's t test for unpaired data was used to assess statistical significance of the difference between patients with CBE and without CBE. A paired t test was used to compare the difference within 7 days of the onset and 2 weeks after the first study in patients with CBE. P values of less than 0.05 were considered significant.
Results
There were no significant differences in age, sex, blood pressure, heart rate and the prevalence of hypertension, diabetes and current smokers between the groups. The PAF duration after admission was 22±6 hours in group CBE and 24±6 hours in group N (NS). The duration from reversal to normal sinus rhythm to TEE examinations was 6±1 days in b oth groups (NS) ( Table  1 ).
There were no significant differences in left atrial dimension, left ventricular end-diastolic dimension and percent fractional shortening, ASA, PFO and aortic IMT between the groups. Group CBE had significantly larger LAA area, Group N, paroxysmal atrial fibrillation patients without CBE; BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate, PAF duration: the duration of the episode of paroxysmal atrial fibrillation after the admission, Periods after reversal, the duration from reversal to normal sinus rhythm to first echocardiographic examinations. Figure 1 . Representative traces of fractional area change of the left atrial appendage (LAA-FAC)in a paroxysmal atrial fibrillation patient with acute cardiogenic brain embolism (CBE) and one without CBE(Control). Both the patient with CBEand the control subject had atrial fibrillation on admission, and were examined by echocardiographic studies 6 days after recovery to normal sinus rhythm. The patient with CBEhad a markedly lower LAA-FACthan the control subject (LAA area: 4.0 cm2 vs. 3.8 cm2; LAA-FAC: 25% vs. 90%). Top, patient with CBE;Bottom, control subject; Right, maximumLAAarea; Left, minimumLAAarea (transverse plane by transesophageal echocardiograms). It has been clearly shown that left atrial dysfunction due to atrial stunning can be recovered for dozens of minutes after the cessation of PAF, whereas, prolongation of the atrial stunning has been suggested to play a critical role in the thrombus formation in LAA by experimental studies (39) (40) (41) (42) Previous clinical reports demonstrate that the nature of altered coagulation and fibrinolysis are different in various subtypes of ischemic stroke (45) . Especially, plasma levels of D-dimer and thrombin-antithrombin III complex are significantly higher in cases with cardioembolic stroke, compared with atherothrombotic or lacunar stroke (46) . Therefore, screening of the prethrombotic state using these hemostatic markers is useful for the assessment and identification of stroke subtype (45, 46) . On the other hand, it has been reported that there are no significant differences in fibrinocoagulation activity (including D-dimer) between patients with PAF (including paroxysmal periods) and normal sinus controls (47, 48) . Then, patients with CBE in the present study also had significantly higher levels of D-dimer than controls in spite of similar ages and levels of prevalence of stroke risk factor, ASA, PFO, aortic IMT and left ventricular function between the two groups. Furthermore, even LAA thrombus was not found in 13 out of 16 patients with CBE (81%).
Our study demonstrated that impairment of LAA-FAC evaluated by TEE might provide the direct evidence that sustained dysfunction of LAA contributes to the occurr ence of CBE in patients with PAF with unknown origins. The present study had the following limitations. First, the number of subjects was small. Secondly, it was not easy to assess the LAA function with two-dimensional echocardio- 
